Cart
sales@molnova.com
SU0268
CAS No. 2210228-45-6
SU0268( —— )
Catalog No. M23997 CAS No. 2210228-45-6
SU0268 is a potent and specific 8-Oxoguanine DNA glycosylase 1 (OGG1) inhibitor. SU0268 regulates inflammatory responses during Pseudomonas aeruginosa infection.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 93 | In Stock |
|
| 5MG | 92 | In Stock |
|
| 10MG | 147 | In Stock |
|
| 25MG | 306 | In Stock |
|
| 50MG | 477 | In Stock |
|
| 100MG | 695 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSU0268
-
NoteResearch use only, not for human use.
-
Brief DescriptionSU0268 is a potent and specific 8-Oxoguanine DNA glycosylase 1 (OGG1) inhibitor. SU0268 regulates inflammatory responses during Pseudomonas aeruginosa infection.
-
DescriptionSU0268 is a potent and specific 8-Oxoguanine DNA glycosylase 1 (OGG1) inhibitor. SU0268 regulates inflammatory responses during Pseudomonas aeruginosa infection.
-
In VitroCell Viability Assay Cell Line:A549 shGFP and shMTH1 (2000 cells per well).Concentration:0.1 μM, 0.5 μM, 1 μM, 2.5 μM, 5 μM, 7.5 μM, 10 μM.Incubation Time:24 or 48 h.Result:The shGFP cells were more susceptible to OGG1 inhibition via increasing SU0268 doses than the shMTH1 cells, especially at the 48 time-point.
-
In VivoAnimal Model:Anesthetized C57BL/6N mice.Dosage:10 mg/kg.Administration:Intranasally treated.Result:Significantly inhibits inflammatory responses and mitigates P. aeruginosa infection.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor8-oxoguanine DNA glycosylase 1 (OGG1)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2210228-45-6
-
Formula Weight475.56
-
Molecular FormulaC26H25N3O4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (210.28 mM; Need ultrasonic)
-
SMILESO=C(C1=CC(C2=CC=C(S(=O)(NC3=CC4=C(C=C3)CCCN4C(C5CC5)=O)=O)C=C2)=CC=C1)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ling Zhang, et al. OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1. Redox Biol. 2021 Apr;40:101848.
molnova catalog
related products
-
Vonlerolizumab
Vonlerolizumab(MOXR 0916) is a humanized IgG agonistic OX40-specific monoclonal antibody with potential antitumor activity for the study of tumors and immune diseases.
-
SJF 1521
SJF 1521 is an EGFR degrader belonging to the PROTAC class that selectively degrades EGFR while preserving HER2.
-
Phenyl-ac-Gly-OH
Phenylacetylglycine is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. The presence of phenylacetylglycine in urine has been confirmed for dogs rats and mice. However the presence of this compound in human urine is controversial. GC-MS studies have not found this compound while NMR studies claimed to have identified it.
